Received Sep 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | A32BB | — |
expired drug used; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 5-year-old female patient who received DTPa-HBV-IPV (Pediarix) (batch number A32BB, expiry date 10-AUG-2025) for prophylaxis. On 19-AUG-2025, the patient received Pediarix. On 19-AUG-2025, an unknown time after receiving Pediarix, the patient experienced expired vaccine used (Verbatim: expired drug used). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 22-Aug-2025 Clinical Supervisor reported that a dose of expired Pediarix was administered to patient.